Yara Dixon Shares Interesting Study on Heavy Menstrual Bleeding in Young Women
Yara Dixon, MD and PhD candidate in pediatric hematology and sociology at Erasmus MC, has shared a post on Linkedin:
“Excited to announce my first publication!
Our article, ‘Management of heavy menstrual bleeding in a multidisciplinary young women’s clinic: a Dutch experience’, is now published in RPTH Journal. |
Of course, there’s no better topic for my first publication.
We reviewed cases of young women with heavy menstrual bleeding (HMB) at a specialized Dutch clinic.
Key findings from our study:
- HMB is common and significantly impacts quality of life.
- ~20% had an undiagnosed bleeding disorder — most often von Willebrand disease.
- A combination of tranexamic acid and hormonal therapy proved to be most effective.
This milestone represents years of collaboration and dedication.
I’m grateful to Bart Kabboord for completing the dataset after my graduation, and to the HMB outpatient team at Erasmus MC, including C. Heleen van Ommen, Carla Groenestein‑Sondaal, Marieke Kruip, Carolien van der Velden-van ‘ and Greta Mulders. Lastly, a special thank you to my mentor C. Heleen van Ommen for her unwavering support since the start of my master’s thesis in 2020.
Here’s to many more! ”
Read the full article here.
Title: Management of heavy menstrual bleeding in a multidisciplinary young women’s clinic: a Dutch experience
Authors: Yara Dixon, Bart Kabboord, Carla Groenestein-Sondaal, Marieke J.H.A. Kruip, Carolien van der Velden, Greta Mulders, C. Heleen van Ommen
Stay updated on the latest scientific advancements in the field of bleeding disorders with Hemostasis Today.
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals